Related Experiment Video
Updated: Sep 26, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Budding yeast in a child with acute leukemia: Nothing CRYPT(O)IC about it
Rimjhim Kanaujia1, Subramaniam Ramanathan2, Rahul Sarode3
1Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
A rare case of disseminated cryptococcosis in a child with acute lymphoblastic leukemia is presented. The study highlights identifying Cryptococcus in blood cultures and unique Buckminsterfullerene-like structures.
Area of Science:
- Medical Mycology
- Hematology
- Pediatric Oncology
Background:
- Disseminated cryptococcosis is a rare fungal infection, particularly in immunocompromised pediatric patients.
- Acute lymphoblastic leukemia (ALL) treatment can increase the risk of opportunistic infections like cryptococcosis.
- Early detection of fungal pathogens in blood cultures is crucial for timely management.
Observation:
- A 13-year-old girl with B-cell precursor ALL presented with fever, fatigue, and an iliac mass.
- Blood cultures revealed budding yeast cells, indicative of Cryptococcus.
- Unusual crystalloid geometric structures resembling Buckminsterfullerene were observed, derived from the Cryptococcus capsule.
Findings:
- The case represents a rare instance of disseminated cryptococcosis in a pediatric leukemia patient.
- Identification of Cryptococcus from Gram stains can be challenging, underscoring the importance of yeast morphology in blood cultures.
- The presence of Buckminsterfullerene-like structures is a rare and remarkable finding.
Implications:
- This case emphasizes the need for a broad differential diagnosis for yeast in blood cultures of immunocompromised children.
- Recognizing unique fungal structures can aid in diagnosis and understanding pathogen-host interactions.
- Further research into the formation and significance of these crystalloid structures in Cryptococcus is warranted.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Yeast Signaling
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...